6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one
Star0
Identification
- Generic Name
- 6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one
- DrugBank Accession Number
- DB08267
- Background
6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one is a solid. This compound belongs to the stilbenes. These are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6) are derived from the common phenylpropene (C6-C3) skeleton building block. The introduction of one or more hydroxyl groups to a phenyl ring lead to stilbenoids. It is known to target queuine tRNA-ribosyltransferase.
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 305.3339
Monoisotopic: 305.127660127 - Chemical Formula
- C17H15N5O
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UQueuine tRNA-ribosyltransferase Not Available Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4) - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as stilbenes. These are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6 ) are derived from the common phenylpropene (C6-C3) skeleton building block. The introduction of one or more hydroxyl groups to a phenyl ring lead to stilbenoids.
- Kingdom
- Organic compounds
- Super Class
- Phenylpropanoids and polyketides
- Class
- Stilbenes
- Sub Class
- Not Available
- Direct Parent
- Stilbenes
- Alternative Parents
- Quinazolinamines / Benzimidazoles / Pyrimidones / Aminopyrimidines and derivatives / Benzene and substituted derivatives / Vinylogous amides / Imidazoles / Heteroaromatic compounds / Azacyclic compounds / Primary amines show 4 more
- Substituents
- Amine / Aminopyrimidine / Aromatic heteropolycyclic compound / Azacycle / Azole / Benzenoid / Benzimidazole / Diazanaphthalene / Heteroaromatic compound / Hydrocarbon derivative show 16 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- PBZAIUVFRISTSZ-UHFFFAOYSA-N
- InChI
- InChI=1S/C17H15N5O/c18-17-21-14-11(7-6-10-4-2-1-3-5-10)15-13(19-9-20-15)8-12(14)16(23)22-17/h1-5,8-9H,6-7H2,(H,19,20)(H3,18,21,22,23)
- IUPAC Name
- 6-amino-4-(2-phenylethyl)-1H,7H,8H-imidazo[4,5-g]quinazolin-8-one
- SMILES
- NC1=NC2=C(C=C3NC=NC3=C2CCC2=CC=CC=C2)C(=O)N1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 5326928
- PubChem Substance
- 99444738
- ChemSpider
- 4484211
- ZINC
- ZINC000033836604
- PDBe Ligand
- NE8
- PDB Entries
- 1y5v / 5i07 / 6ygr / 6ygz
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0325 mg/mL ALOGPS logP 1.91 ALOGPS logP 2.32 Chemaxon logS -4 ALOGPS pKa (Strongest Acidic) 11.09 Chemaxon pKa (Strongest Basic) 4.15 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 96.16 Å2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 89.44 m3·mol-1 Chemaxon Polarizability 32.31 Å3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9638 Blood Brain Barrier + 0.9797 Caco-2 permeable - 0.6195 P-glycoprotein substrate Non-substrate 0.6014 P-glycoprotein inhibitor I Non-inhibitor 0.8197 P-glycoprotein inhibitor II Non-inhibitor 0.7344 Renal organic cation transporter Non-inhibitor 0.627 CYP450 2C9 substrate Non-substrate 0.8077 CYP450 2D6 substrate Non-substrate 0.7585 CYP450 3A4 substrate Non-substrate 0.6259 CYP450 1A2 substrate Non-inhibitor 0.5221 CYP450 2C9 inhibitor Non-inhibitor 0.8084 CYP450 2D6 inhibitor Non-inhibitor 0.6787 CYP450 2C19 inhibitor Non-inhibitor 0.72 CYP450 3A4 inhibitor Non-inhibitor 0.6949 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.5515 Ames test Non AMES toxic 0.5424 Carcinogenicity Non-carcinogens 0.9675 Biodegradation Not ready biodegradable 0.9961 Rat acute toxicity 2.3915 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.8799 hERG inhibition (predictor II) Non-inhibitor 0.7858
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0a4i-0009000000-d7fd1124ba24c89ed951 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0f79-0095000000-24f081916916891f887a Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0a4i-0019000000-3bda6dc6b42faa111d78 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-0kto-2092000000-5805c5751c2d7f33d413 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-06z0-0391000000-d40d6cf16ba82053e0f9 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-000f-4490000000-5df212cbf0e485e5a7d1 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 166.0865 predictedDeepCCS 1.0 (2019) [M+H]+ 168.4445 predictedDeepCCS 1.0 (2019) [M+Na]+ 174.53764 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsQueuine tRNA-ribosyltransferase
- Kind
- Protein
- Organism
- Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)
- Pharmacological action
- Unknown
- General Function
- Queuine trna-ribosyltransferase activity
- Specific Function
- Exchanges the guanine residue with 7-aminomethyl-7-deazaguanine in tRNAs with GU(N) anticodons (tRNA-Asp, -Asn, -His and -Tyr). After this exchange, a cyclopentendiol moiety is attached to the 7-am...
- Gene Name
- tgt
- Uniprot ID
- P28720
- Uniprot Name
- Queuine tRNA-ribosyltransferase
- Molecular Weight
- 42842.235 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:30 / Updated at June 12, 2020 16:52